Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana Rabara

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Analytical Chemistry|March 18, 2024
A Top-Down Proteomic Assay to Evaluate KRAS4B-Compound EngagementRobert A D'Ippolito, Dana Rabara, Maria Abreu Blanco, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J Kwon, Julien Dilly, Shengwu Liu, et al.
Cancer Discovery|March 6, 2026
Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic MutantsCarlos Stahlhut, Anna E Maciag, Kyle A Sullivan, et al.
Cancer Discovery|December 6, 2024
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12CAnna E Maciag, James P Stice, Bin Wang, et al.
Science (New York, N.Y.)|June 12, 2025
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interactionDhirendra K Simanshu, Rui Xu, James P Stice, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Analytical Chemistry|March 18, 2024
A Top-Down Proteomic Assay to Evaluate KRAS4B-Compound EngagementRobert A D'Ippolito, Dana Rabara, Maria Abreu Blanco, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J Kwon, Julien Dilly, Shengwu Liu, et al.
Cancer Discovery|March 6, 2026
Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic MutantsCarlos Stahlhut, Anna E Maciag, Kyle A Sullivan, et al.
Cancer Discovery|December 6, 2024
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12CAnna E Maciag, James P Stice, Bin Wang, et al.
Science (New York, N.Y.)|June 12, 2025
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interactionDhirendra K Simanshu, Rui Xu, James P Stice, et al.
Pageof 2